Fatty liver index associates with relative sarcopenia and GH/IGF-1 status in obese subjects

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Poggiogalle, Eleonora ^a   Lubrano, Carla ^a   Gnessi, Lucio ^a   Mariani, Stefania ^a   Lenzi, Andrea ^a   Donini, Lorenzo Maria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; GHRELIN;

ADULT; AGED; APPENDICULAR SKELETAL MUSCLE; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE ASSOCIATION; FAT FREE MASS; FAT MASS; FATTY LIVER INDEX; FEMALE; HUMAN; INSULIN SENSITIVITY; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; RISK FACTOR; SARCOPENIA; SKELETAL MUSCLE; TRUNCAL FAT MASS; COMPLICATION; FATTY LIVER; GENE EXPRESSION; GENETICS; INSULIN RESISTANCE; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; STATISTICAL MODEL;

ADULT; BODY COMPOSITION; BODY MASS INDEX; FATTY LIVER; FEMALE; GENE EXPRESSION; GHRELIN; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; LIVER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; SARCOPENIA;

EID: 84954150392     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145811     Document Type: Article

References (39)

1. Waters DL, Baumgartner RN. Sarcopenia and obesity. Clin Geriatr Med 2011;27:401-21. doi: 10. 1016/j.cger.2011.03.007 PMID: 21824555
2. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011;12:249-56. doi: 10.1016/j. jamda.2011.01.003 PMID: 21527165
3. Poggiogalle E, Migliaccio S, Lenzi A, Donini LM. Treatment of body composition changes in obese and overweight older adults: insight into the phenotype of sarcopenic obesity. Endocrine 2014;47:699-716. doi: 10.1007/s12020-014-0315-x PMID: 24952725
4. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: A Critical appraisal of the current evidence Clin Nutr. 2012;31:583-601. doi: 10.1016/j.clnu.2012.06.010 PMID: 22809635
5. Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol 2014;28:637-53. doi: 10.1016/j.bpg.2014.07.008 PMID: 25194181
6. Moon JS, Yoon JS, Won KC, Lee HW. The role of skeletal muscle in development of nonalcoholic Fatty liver disease. Diabetes Metab J 2013;37:278-85. doi: 10.4093/dmj.2013.37.4.278 PMID: 23991406
7. Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology 2014;59:1772-8. doi: 10.1002/hep. 26716 PMID: 23996808
8. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014;371:1131-41. doi: 10.1056/NEJMra1011035 PMID: 25229917
9. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2011;96:2898-903. doi: 10.1210/jc.2011-0435 PMID: 21778224
10. Berryman DE, Glad CA, List EO, Johannsson G. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat Rev Endocrinol 2013;9:346-56. doi: 10.1038/nrendo.2013.64 PMID: 23568441
11. Brick DJ, Gerweck AV, Meenaghan E, Lawson EA, Misra M, Fazeli P, et al. Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity. Eur J Endocrinol 2010;163:185-91. doi: 10.1530/EJE-10-0365 PMID: 20501597
12. Lubrano C, Tenuta M, Costantini D, Specchia P, Barbaro G, Basciani S, et al. Severe growth hormone deficiency and empty sella in obesity: a cross-sectional study. Endocrine 2015;49:503-11. doi: 10. 1007/s12020-015-0530-0 PMID: 25614038
13. Takahashi Y. Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver. Endocr J 2012;59:955-62. PMID: 22986486
14. Xu L, Xu C, Yu C, Miao M, Zhang X, Zhu Z, et al. Association between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional study. PLoS One 2012;7:e44136. doi: 10.1371/journal.pone.0044136 PMID: 22952901
15. Franco C, Veldhuis JD, Iranmanesh A, Brandberg J, Lönn L, Andersson B, et al. Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity. Eur J Endocrinol 2006;155:261-8. PMID: 16868139
16. Junnila RK, List EO, Berryman DE, Murrey JW, Kopchick JJ. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol 2013;9:366-76. doi: 10.1038/nrendo.2013.67 PMID: 23591370
17. Guichelaar MM, Charlton MR. Decreased muscle mass in nonalcoholic fatty liver disease: new evidence of a link between growth hormone and fatty liver disease? Hepatology 2014;59:1668-70. doi: 10.1002/hep. 27058 PMID: 24691865
18. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998;22:1164-71. PMID: 9877251
19. Lohman TJ, Roache AF, Martorell R. Antropometric standardization reference manual. Med Sci Sports Exerc 2002;24:952
20. Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, Wang J, et al. Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr 1990;52:214-218. PMID: 2375286
21. Siervo M, Prado CM, Mire E, Broyles S, Wells JC, Heymsfield S, et al. Body composition indices of a load-capacity model: gender- and BMI-specific reference curves. Public Health Nutr 2014;15:1-10.
22. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470. PMID: 10480510
23. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006;6:33. PMID: 17081293
24. Gastaldelli A, Kozakova M, Hojlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009;49:1537-44. doi: 10.1002/hep. 22845 PMID: 19291789
25. Bredella MA, Torriani M, Thomas BJ, Ghomi RH, Brick DJ, Gerweck AV, et al. Peak growth hormonereleasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. J Clin Endocrinol Metab. 2009;94:3995-4002. doi: 10.1210/jc.2009-0438 PMID: 19602559
26. Arturi F, Succurro E, Procopio C, Pedace E, Mannino GC, Lugarà M, et al. Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab. 2011;96:E1640-4. doi: 10.1210/jc.2011-1227 PMID: 21816784
27. Völzke H, Nauck M, Rettig R, Dörr M, Higham C, Brabant G, et al. Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. Eur J Endocrinol. 2009;161:705-13. doi: 10.1530/EJE-09-0374 PMID: 19690083
28. Runchey SS, Boyko EJ, Ioannou GN, Utzschneider KM. Relationship between serum circulating insulinlike growth factor-1 and liver fat in the United States. J Gastroenterol Hepatol. 2014;29:589-96. PMID: 24716226
29. Martinez-Hervas S, Argente C, Garcia-Jodar J, Priego A, Real JT, Carratala A, et al. Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a postprandial method based on oral glucose tolerance test. Metabolism 2011;60:740-6. doi: 10.1016/j.metabol.2010.07.024 PMID: 20850158
30. Byrne CD, Targher G. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol 2014;34:1155-61. doi: 10.1161/ATVBAHA. 114.303034 PMID: 24743428
31. Guillet C, Boirie Y. Insulin resistance: a contributing factor to age-related muscle mass loss? Diabetes Metab 2005;31:5S20-5S26. PMID: 16415762
32. Gallagher D, DeLegge M. Body composition (sarcopenia) in obese patients: implications for care in the intensive care unit. JPEN J Parenter Enteral Nutr 2011;35:21S-8S. doi: 10.1177/0148607111413773 PMID: 21807929
33. Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F. The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 2010;205:201-10. doi: 10.1677/JOE-09-0431 PMID: 20197302
34. Donini LM, Poggiogalle E, Migliaccio S, Aversa A, Pinto A. Body composition in sarcopenic obesity: systematic review of the literature. Mediterr J Nutr Metab 2013;6:191-198
35. Kim TN, Park MS, Lim KI, Choi HY, Yang SJ, Yoo HJ, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study. Clin Endocrinol (Oxf) 2013;78:525-32.
36. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010;33:1652-4. doi: 10.2337/dc10-0107 PMID: 20460442
37. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889-96. PMID: 12028177
38. Cuthbertson DJ, Weickert MO, Lythgoe D, Sprung VS, Dobson R, Shoajee-Moradie F, et al. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. Eur J Endocrinol. 2014;171:561-9. doi: 10.1530/EJE-14-0112 PMID: 25298375
39. Gielen E, O'Neill TW, Pye SR, Adams JE, Wu FC, Laurent MR, et al. Endocrine determinants of incident sarcopenia in middle-aged and elderly European men. J Cachexia Sarcopenia Muscle. 2015;6:242-52. doi: 10.1002/jcsm.12030 PMID: 26401471